BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pazgan-Simon M, Kukla M, Zuwała-Jagiełło J, Derra A, Bator M, Menżyk T, Lekstan A, Grzebyk E, Simon K. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC). PLoS One 2020;15:e0227459. [PMID: 31935230 DOI: 10.1371/journal.pone.0227459] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ismaiel A, Leucuta DC, Popa SL, Dumitrascu DL. Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis. J Clin Med 2021;10:3029. [PMID: 34300193 DOI: 10.3390/jcm10143029] [Reference Citation Analysis]
2 Ding H, Liu J, Wang C, Su Y. NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA. Cancer Cell Int 2020;20:425. [PMID: 32884448 DOI: 10.1186/s12935-020-01520-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mannelli M, Gamberi T, Magherini F, Fiaschi T. The Adipokines in Cancer Cachexia. Int J Mol Sci 2020;21:E4860. [PMID: 32660156 DOI: 10.3390/ijms21144860] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shi GY, Sun Y, Liang XC, Xie JD. Clinical significance of expression of serum insulin-like growth factor-1 in patients with primary liver cancer and diabetes mellitus. Shijie Huaren Xiaohua Zazhi 2021; 29(5): 236-241 [DOI: 10.11569/wcjd.v29.i5.236] [Reference Citation Analysis]